Concentrix Corporation (NASDAQ:CNXC) Given Average Rating of “Hold” by Analysts

Shares of Concentrix Corporation (NASDAQ:CNXC) have received an average recommendation of “Hold” from the five brokerages that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $63.75.

A number of research analysts recently issued reports on CNXC shares. Wall Street Zen lowered shares of Concentrix from a “buy” rating to a “hold” rating in a research note on Saturday, January 17th. Weiss Ratings downgraded Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research report on Thursday, January 29th. Barrington Research restated an “outperform” rating and set a $62.00 target price on shares of Concentrix in a research note on Monday, January 12th. Finally, Robert W. Baird set a $52.00 price target on Concentrix in a research report on Wednesday, January 14th.

Concentrix Stock Performance

Shares of NASDAQ CNXC opened at $39.93 on Friday. The business’s 50-day simple moving average is $40.37 and its 200-day simple moving average is $44.62. The company has a debt-to-equity ratio of 1.67, a quick ratio of 1.40 and a current ratio of 1.40. Concentrix has a 52 week low of $31.63 and a 52 week high of $66.00. The firm has a market cap of $2.46 billion, a price-to-earnings ratio of -1.92, a P/E/G ratio of 0.42 and a beta of 0.50.

Concentrix (NASDAQ:CNXC) last announced its earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.93 by $0.02. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.The firm had revenue of $2.55 billion during the quarter, compared to analysts’ expectations of $2.54 billion. During the same quarter in the prior year, the business earned $3.26 earnings per share. The company’s revenue was up 4.3% on a year-over-year basis. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. As a group, equities research analysts expect that Concentrix will post 10.11 earnings per share for the current fiscal year.

Concentrix Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 10th. Investors of record on Friday, January 30th will be paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 3.6%. The ex-dividend date is Friday, January 30th. Concentrix’s dividend payout ratio is presently -6.91%.

Insider Transactions at Concentrix

In related news, CEO Christopher A. Caldwell acquired 1,000 shares of the company’s stock in a transaction dated Thursday, January 29th. The shares were bought at an average price of $37.07 per share, for a total transaction of $37,070.00. Following the acquisition, the chief executive officer owned 362,075 shares in the company, valued at $13,422,120.25. This trade represents a 0.28% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 3.20% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Concentrix

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Huntington National Bank grew its holdings in shares of Concentrix by 6,011.1% during the 3rd quarter. Huntington National Bank now owns 550 shares of the company’s stock worth $25,000 after purchasing an additional 541 shares in the last quarter. Quent Capital LLC acquired a new position in shares of Concentrix in the third quarter valued at $29,000. Larson Financial Group LLC lifted its position in Concentrix by 224.9% in the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock worth $32,000 after purchasing an additional 479 shares during the period. Geneos Wealth Management Inc. boosted its stake in Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after buying an additional 522 shares in the last quarter. Finally, Rothschild Investment LLC boosted its stake in Concentrix by 14,980.0% during the third quarter. Rothschild Investment LLC now owns 754 shares of the company’s stock worth $35,000 after buying an additional 749 shares in the last quarter. 90.34% of the stock is currently owned by institutional investors.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.